{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:26:45Z","timestamp":1766557605070},"reference-count":21,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ejphar.2005.01.056","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T13:28:54Z","timestamp":1112621334000},"page":"207-213","source":"Crossref","is-referenced-by-count":16,"title":["The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium"],"prefix":"10.1016","volume":"512","author":[{"given":"Mar\u00eda Jes\u00fas","family":"Juan-Fita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.01.056_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2005.01.056_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.RES.68.4.1070","article-title":"Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue","volume":"68","author":"Bode","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2005.01.056_bib3","first-page":"1","article-title":"The molecular biology of cyclic nucleotide phosphodiesterases","volume":"63","author":"Conti","year":"1999","journal-title":"Adv. Nucleic Acid Res."},{"key":"10.1016\/j.ejphar.2005.01.056_bib4","first-page":"S13","article-title":"Treatment of the acute descompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department","volume":"4","author":"Emerman","year":"2004","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2005.01.056_bib5","series-title":"Cardiovascular Drugs and the Management of Heart Disease","first-page":"65","article-title":"Dopamine and dobutamine: pharmacology and use in advanced heart failure","author":"Ewy","year":"1992"},{"key":"10.1016\/j.ejphar.2005.01.056_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0968-0004(97)01050-5","article-title":"Tailoring cAMP-signalling responses through isoform multiplicity","volume":"22","author":"Houslay","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2005.01.056_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-0773.2003.930103.x","article-title":"Comparative actions of diazepam and other phosphodiesterase inhibitors on the effects of noradrenaline in rat myocardium","volume":"93","author":"Juan-Fita","year":"2003","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00210-004-0978-6","article-title":"Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium","volume":"370","author":"Juan-Fita","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00005344-199205000-00005","article-title":"Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone and isobutylmethylxantine","volume":"20","author":"Katano","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1476-5381.1995.tb16384.x","article-title":"Determination of \u03b2-adrenoceptor subtype in ventricular myocytes by use of highly selective \u03b2-antagonists","volume":"116","author":"Kitagawa","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib12","first-page":"798","article-title":"Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparation on the rat and guinea pig","volume":"217","author":"MacLeod","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.01.056_bib11","first-page":"597","article-title":"The effect of dobutamine on rat cardiac cyclic AMP, phosphorilase and force of contraction","volume":"20","author":"McNeill","year":"1978","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/345158a0","article-title":"Glucagon stimulated the cardiac Ca+2 current by activation of adenylyl cyclase and inhibition of phosphodiesterase","volume":"345","author":"M\u00e9ry","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2005.01.056_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.RES.0000134629.84732.11","article-title":"Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartimentalized phosphodiesterases","volume":"95","author":"Mongillo","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2005.01.056_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-6147(91)90484-A","article-title":"Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes","volume":"12","author":"Nicholson","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2005.01.056_bib16","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1172\/JCI119460","article-title":"cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes","volume":"99","author":"Rivet-Bastide","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2005.01.056_bib17","first-page":"H1088","article-title":"Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes","volume":"257","author":"Romano","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/jm00247a002","article-title":"Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines","volume":"17","author":"Schaeffer","year":"1974","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2005.01.056_bib19","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1073\/pnas.81.19.6044","article-title":"Erythro-9-(3-2(hydroxynonyl))adenine is an effective inhibitor of cell motility and actin assembly","volume":"81","author":"Schliwa","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2005.01.056_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjp.0702506","article-title":"Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes","volume":"127","author":"Verde","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.01.056_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/009127009903900502","article-title":"A review of potential cardiovascular uses of intravenous glucagon administration","volume":"39","author":"White","year":"1999","journal-title":"J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T20:52:34Z","timestamp":1683060754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":21,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0014299905001548"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.01.056","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}